Zosano Pharma Receives Complete Response Letter from FDA for Qtrypta™
21 oct. 2020 08h30 HE
|
Zosano Pharma Corporation
--FDA feedback consistent with FDA’s preliminary communication in September----Company requesting meeting with FDA to discuss next steps required to resubmit the NDA-- FREMONT, Calif., Oct. 21, 2020...
Zosano Pharma Receives Preliminary FDA Communication on Qtrypta™ NDA
30 sept. 2020 17h40 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Sept. 30, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company today announced that it has received a discipline review...
Zosano Pharma to Present at the Cantor Virtual Global Healthcare Conference
09 sept. 2020 08h30 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive...
Zosano Pharma to Present at the H.C. Wainwright Annual Global Investment Conference
03 sept. 2020 08h00 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive...
Zosano Announces Pricing of Public Offering of Common Stock
01 sept. 2020 09h00 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten public...
Zosano Pharma Announces Proposed Public Offering of Common Stock
31 août 2020 16h05 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has commenced an underwritten public...
Zosano Pharma Announces Agreement to Collaborate with Mitsubishi Tanabe Pharma Corporation
18 août 2020 08h30 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that it has entered into a feasibility study...
Zosano Pharma Announces Partnership Agreement with EVERSANA to Support the Launch and Commercialization of Qtrypta™
06 août 2020 17h00 HE
|
Zosano Pharma Corporation
Agreement outlines commercialization and distribution execution strategy upon FDA approval EVERSANA to provide commercial services of approximately $250 million over 5 years FREMONT, Calif.,...
Zosano Pharma Reports Second Quarter 2020 Financial Results and Provides Corporate Update
06 août 2020 08h00 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the second quarter ended...
Zosano Pharma to Present at the BTIG Biotechnology Conference 2020
03 août 2020 16h05 HE
|
Zosano Pharma Corporation
FREMONT, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive...